Pacific Smiles Group Future Growth

Future criteria checks 4/6

Pacific Smiles Group is forecast to grow earnings and revenue by 16.3% and 7.2% per annum respectively. EPS is expected to grow by 16.7% per annum. Return on equity is forecast to be 25% in 3 years.

Key information

16.3%

Earnings growth rate

16.7%

EPS growth rate

Healthcare earnings growth	22.8%
Revenue growth rate	7.2%
Future return on equity	25.0%
Analyst coverage	Low
Last updated	28 Dec 2024

Recent future growth updates

Recent updates

Market Participants Recognise Pacific Smiles Group Limited's (ASX:PSQ) Revenues Pushing Shares 58% Higher

Dec 27

Some Investors May Be Worried About Pacific Smiles Group's (ASX:PSQ) Returns On Capital

Dec 19

Should You Investigate Pacific Smiles Group Limited (ASX:PSQ) At AU$2.56?

Mar 17

Investors Who Bought Pacific Smiles Group (ASX:PSQ) Shares Three Years Ago Are Now Up 65%

Mar 02

With EPS Growth And More, Pacific Smiles Group (ASX:PSQ) Is Interesting

Feb 18

Here's Why We Think Pacific Smiles Group's (ASX:PSQ) Statutory Earnings Might Be Conservative

Feb 08

Here's What Pacific Smiles Group Limited's (ASX:PSQ) Shareholder Ownership Structure Looks Like

Jan 27

Pacific Smiles Group Limited (ASX:PSQ) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Jan 15

Here's What To Make Of Pacific Smiles Group's (ASX:PSQ) Returns On Capital

Jan 03

Read This Before Selling Pacific Smiles Group Limited (ASX:PSQ) Shares

Dec 22

Earnings and Revenue Growth Forecasts

ASX:PSQ - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2027	223	13	33	49	3
6/30/2026	212	12	29	45	3
6/30/2025	196	10	33	41	3
6/30/2024	180	8	29	33	N/A
3/31/2024	178	7	33	37	N/A
12/31/2023	175	7	36	42	N/A
9/30/2023	171	5	33	41	N/A
6/30/2023	167	2	30	41	N/A
3/31/2023	161	0	21	34	N/A
12/31/2022	155	-2	11	27	N/A
9/30/2022	147	-3	3	23	N/A
6/30/2022	140	-5	-5	18	N/A
3/31/2022	141	-2	-8	18	N/A
12/31/2021	142	1	-11	17	N/A
9/30/2021	148	7	1	28	N/A
6/30/2021	153	13	13	39	N/A
3/31/2021	142	13	19	39	N/A
12/31/2020	131	12	25	40	N/A
9/30/2020	125	9	22	34	N/A
6/30/2020	120	6	18	29	N/A
3/31/2020	125	7	15	29	N/A
12/31/2019	130	8	12	29	N/A
9/30/2019	126	9	8	25	N/A
6/30/2019	122	9	4	21	N/A
3/31/2019	118	8	3	19	N/A
12/31/2018	114	8	2	16	N/A
9/30/2018	109	7	3	17	N/A
6/30/2018	105	7	4	17	N/A
3/31/2018	100	7	N/A	17	N/A
12/31/2017	96	7	N/A	16	N/A
9/30/2017	94	9	N/A	17	N/A
6/30/2017	91	10	N/A	17	N/A
3/31/2017	89	10	N/A	17	N/A
12/31/2016	87	10	N/A	17	N/A
9/30/2016	85	10	N/A	15	N/A
6/30/2016	83	10	N/A	13	N/A
3/31/2016	81	10	N/A	13	N/A
12/31/2015	79	10	N/A	14	N/A
9/30/2015	77	9	N/A	14	N/A
6/30/2015	75	8	N/A	14	N/A
3/31/2015	71	8	N/A	15	N/A
12/31/2014	68	7	N/A	16	N/A
9/30/2014	63	7	N/A	15	N/A
6/30/2014	59	8	N/A	13	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PSQ's forecast earnings growth (16.3% per year) is above the savings rate (2.6%).

Earnings vs Market: PSQ's earnings (16.3% per year) are forecast to grow faster than the Australian market (12.4% per year).

High Growth Earnings: PSQ's earnings are forecast to grow, but not significantly.

Revenue vs Market: PSQ's revenue (7.2% per year) is forecast to grow faster than the Australian market (6% per year).

High Growth Revenue: PSQ's revenue (7.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PSQ's Return on Equity is forecast to be high in 3 years time (25%)

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/06 00:31
End of Day Share Price	2025/02/06 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pacific Smiles Group Limited is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Nicholas Caley	EL&C Baillieu
Russell Wright	Maqro Capital
James Bales	Morgan Stanley

Pacific Smiles Group Future Growth

Future criteria checks 4/6

Key information

Recent future growth updates

Price target increased by 16% to AU$1.90

Price target decreased by 23% to AU$1.30

Consensus EPS estimates fall by 19%

Price target decreased by 14% to AU$1.57

Price target decreased to AU$1.99

Price target decreased to AU$2.15

Recent updates

Pacific Smiles Group Limited Announces Change of Company Secretary

Pacific Smiles Group Limited Announces Change of Company Secretary

Non-Executive Director recently sold AU$75k worth of stock

Pacific Smiles Group Limited Announces Board Resignations

Price target increased by 16% to AU$1.90

Less than half of directors are independent

Pacific Smiles Group Limited, Annual General Meeting, Nov 20, 2024

Pacific Smiles Group Limited Appoints Gary Carroll as Director

Pacific Smiles Group Limited Announces Chief Financial Officer Changes

Pacific Smiles Group Limited Announces the Resignation of Andrew Vidler as Chief Executive Officer

Pacific Smiles Group Limited Announces Resignation of Matthew Cordingley as Chief Financial Officer

Pacific Smiles Group Limited Proposes Fully Franked Final Dividend for the Year Ended 30 June 2024, Payable on 10 October 2024

NDC Holdco Pty Ltd cancelled the acquisition of Pacific Smiles Group Limited (ASX:PSQ) from Genesis Capital Manager I Pty Ltd, HBF Health Limited, MA Financial Group Limited (ASX:MAF), Alison Hughes and others.

Pacific Smiles Group Limited Announces Resignation of Mark Bloom as Non-Executive Director

Upcoming dividend of AU$0.07 per share

Pacific Smiles Group Limited to Report Fiscal Year 2024 Results on Aug 28, 2024

Upcoming dividend of AU$0.07 per share

NDC Holdco Pty Ltd agreed to acquire Pacific Smiles Group Limited (ASX:PSQ) from Genesis Capital Manager I Pty Ltd and other for AUD300 million.

Investor sentiment improves as stock rises 15%

No independent directors

Pacific Smiles Group Limited to Report First Half, 2024 Results on Feb 27, 2024

Market Participants Recognise Pacific Smiles Group Limited's (ASX:PSQ) Revenues Pushing Shares 58% Higher

Pacific Smiles Group Limited Appoints Andrew Vidler as Managing Director, Effective January 15, 2024

Some Investors May Be Worried About Pacific Smiles Group's (ASX:PSQ) Returns On Capital

Investor sentiment improves as stock rises 18%

Non-Executive Director recently bought AU$92k worth of stock

Price target decreased by 23% to AU$1.30

Pacific Smiles Group Limited Appoints Giselle Collins as Director

Consensus EPS estimates fall by 19%

Pacific Smiles Group Limited, Annual General Meeting, Nov 22, 2023

Pacific Smiles Group Announces Simon Rutherford Not Stands for Re-Election as Non-Executive Director and Chair of the Audit & Risk Management Committee

Upcoming dividend of AU$0.023 per share at 1.9% yield

Full year 2023 earnings: EPS and revenues miss analyst expectations

Pacific Smiles Group Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on September 10, 2023

Pacific Smiles Group Limited Announces Chief Executive Officer Changes

Pacific Smiles Group Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Pacific Smiles Group Limited Announces Board Changes

Now 20% undervalued after recent price drop

Pacific Smiles Group Limited Announces Board Changes

Now 24% undervalued after recent price drop

Now 24% undervalued after recent price drop

Price target decreased by 14% to AU$1.57

First half 2023 earnings released: EPS: AU$0.001 (vs AU$0.014 loss in 1H 2022)

Pacific Smiles Group Limited to Report First Half, 2023 Results on Feb 22, 2023

Now 20% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 25% undervalued

Less than half of directors are independent

Pacific Smiles Group Limited, Annual General Meeting, Nov 22, 2022

Price target decreased to AU$1.99

Full year 2022 earnings: EPS and revenues miss analyst expectations

Pacific Smiles Omits to Declare Final Dividend

Price target decreased to AU$2.15

Pacific Smiles Group Limited to Report Fiscal Year 2022 Results on Aug 17, 2022

Price target decreased to AU$2.67

Consensus EPS estimates have been downgraded.

Less than half of directors are independent

Consensus EPS estimates fall by 70%

Pacific Smiles Group Limited Announces No Interim Dividend for the First Half of 2022

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Now 22% undervalued after recent price drop

Pacific Smiles Group Limited Announces Appointment of Andrew Knott as Non-Executive Director

Consensus EPS estimates fall by 31%

Now 22% undervalued after recent price drop

HBF Health Limited acquired 10% stake Pacific Smiles Group Limited (ASX:PSQ) from TDM Growth Partners for approximately AUD 41.9 million.

Non-Executive Director Benjamin Gisz has left the company

Full year 2021 earnings released: EPS AU$0.083 (vs AU$0.042 in FY 2020)

Pacific Smiles Group Limited Provides Earning Guidance for the Fiscal Year 2021

Non-Executive Director recently bought AU$101k worth of stock